Advanced search
Publication Cover
Blood Pressure Volume 26, 2017 - Issue 1
Submit an article Journal homepage
471
Views
6
CrossRef citations to date
0
Altmetric
Original Article

Short- and long-term effects of the use of RAAS blockers immediately after renal transplantation

Christos ChatzikyrkouDivision of Nephrology and Hypertension, Department of Medicine, Hannover Medical School, Hannover, Germany; ;Division of Nephrology and Hypertension, Diabetology and Endocrinology, University Hospital of Magedburg, Magedburg, Germany; Correspondence[email protected]
,
Jenny EichlerDivision of Nephrology and Hypertension, Department of Medicine, Hannover Medical School, Hannover, Germany;
,
Annika KarchInstitute for Biostatistics, Hannover Medical School, Hannover, Germany;
,
Christian ClajusDivision of Nephrology and Hypertension, Department of Medicine, Hannover Medical School, Hannover, Germany;
,
Florian Gunnar ScurtDivision of Nephrology and Hypertension, Diabetology and Endocrinology, University Hospital of Magedburg, Magedburg, Germany;
,
Wolf RamackersDepartment of General, Visceral and Transplantation Surgery, Integrated Research and Treatment Center Transplantation (IFB-Tx), Hannover Medical School, Hannover, Germany
,
Frank LehnerDepartment of General, Visceral and Transplantation Surgery, Integrated Research and Treatment Center Transplantation (IFB-Tx), Hannover Medical School, Hannover, Germany
,
Jan MenneDivision of Nephrology and Hypertension, Department of Medicine, Hannover Medical School, Hannover, Germany;
,
Hermann HallerDivision of Nephrology and Hypertension, Department of Medicine, Hannover Medical School, Hannover, Germany; Correspondence[email protected]
,
Peter R. MertensDivision of Nephrology and Hypertension, Diabetology and Endocrinology, University Hospital of Magedburg, Magedburg, Germany;
&
Mario SchifferDivision of Nephrology and Hypertension, Department of Medicine, Hannover Medical School, Hannover, Germany;
show all
Pages 30-38 | Received 20 Apr 2016, Accepted 22 Apr 2016, Published online: 19 May 2016

References

  • Opelz G, Dohler B, Collaborative Transplant Study. Improved long-term outcomes after renal transplantation associated with blood pressure control. Am J Transplant. 2005;5:2725–2731.
  • Mange KC, Cizman B, Joffe M, et al. Arterial hypertension and renal allograft survival. JAMA. 2000;283:633–638.
  • Collins AJ, Foley RN, Herzog C, et al. US renal data system 2010 annual data report. Am J Kidney Dis. 2011;57:A8, e1–A8, e526.
  • Brenner BM, Cooper ME, de Zeeuw D, et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med. 2001;345:861–869.
  • Chatzikyrkou C, Menne J, Gwinner W, et al. Pathogenesis and management of hypertension after kidney transplantation. J Hypertens. 2011;29:2283–2294.
  • Stevens KK, Patel RK, Clancy M, et al. Angiotensin blockade is associated with early graft dysfunction after live donor renal transplantation. Transplantation. 2010;89:707–709.
  • Paoletti E, Cassottana P, Amidone M, et al. ACE inhibitors and persistent left ventricular hypertrophy after renal transplantation: a randomized clinical trial. Am J Kidney Dis. 2007;50:133–142.
  • Philipp T, Martinez F, Geiger H, et al. Candesartan improves blood pressure control and reduces proteinuria in renal transplant recipients: results from SECRET. Nephrol Dial Transplant. 2010;25:967–976.
  • Paoletti E, Bellino D, Marsano L, et al. Effects of ACE inhibitors on long-term outcome of renal transplant recipients: a randomized controlled trial. Transplantation. 2013;95:889–895.
  • Ibrahim HN, Jackson S, Connaire J, et al. Angiotensin II blockade in kidney transplant recipients. J Am Soc Nephrol. 2013;24:320–327.
  • Abuelo JG. Normotensive ischemic acute renal failure. N Engl J Med. 2007;357:797–805.
  • Correa-Costa M, Azevedo H, Amano MT, et al. Transcriptome analysis of renal ischemia/reperfusion injury and its modulation by ischemic pre-conditioning or hemin treatment. PLoS One. 2012;7:e49569.
  • Cavaille-Coll M, Bala S, Velidedeoglu E, et al. Summary of FDA workshop on ischemia reperfusion injury in kidney transplantation. Am J Transplant. 2013;13:1134–1148.
  • Sulikowski T, Domanski L, Zietek Z, et al. The effect of preservation solutions UW and EC on the expression of renin I, angiotensinogen and angiotensin I-converting enzyme genes in rat kidney. Ann Transplant. 2011;16:108–113.
  • Szczech LA, Granger CB, Dasta JF, et al. Acute kidney injury and cardiovascular outcomes in acute severe hypertension. Circulation. 2010;121:2183–2191.
  • Drenger B, Fontes ML, Miao Y, et al. Patterns of use of perioperative angiotensin-converting enzyme inhibitors in coronary artery bypass graft surgery with cardiopulmonary bypass: effects on in-hospital morbidity and mortality. Circulation. 2012;126:261–269.
  • Bos EM, Wang R, Snijder PM, et al. Cystathionine γ-lyase protects against renal ischemia/reperfusion by modulating oxidative stress. J Am Soc Nephrol. 2013;24:759–770.
  • Mengel M, Chang J, Kayser D, et al. The molecular phenotype of 6-week protocol biopsies from human renal allografts: reflections of prior injury but not future course. Am J Transplant. 2011;11:708–718.
  • Macisaac RJ, Jerums G. Diabetic kidney disease with and without albuminuria. Curr Opin Nephrol Hypertens. 2011;20:246–257.
  • Opelz G, Zeier M, Laux G, et al. No improvement of patient or graft survival in transplant recipients treated with angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers: a collaborative transplant study report. J Am Soc Nephrol. 2006;17:3257–3262.
  • Heinze G, Mitterbauer C, Regele H, et al. Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation. J Am Soc Nephrol. 2006;17:889–899.
  • Hiremath S, Fergusson D, Doucette S, et al. Renin angiotensin system blockade in kidney transplantation: a systematic review of the evidence. Am J Transplant. 2007;7:2350–2360.
  • Sever PS, Chang CL, Prescott MF, et al. Is plasma renin activity a biomarker for the prediction of renal and cardiovascular outcomes in treated hypertensive patients? Observations from the Anglo-Scandinavian cardiac outcomes trial (ASCOT). Eur Heart J. 2012;33:2970–2979.
  • Giral M, Foucher Y, Dufay A, et al. Pretransplant sensitization against angiotensin II Type 1 receptor is a risk factor for acute rejection and graft loss. Am J Transplant. 2013;13:2567–2576.
  • Taniguchi M, Rebellato LM, Cai J, et al. Higher risk of kidney graft failure in the presence of anti-angiotensin II type-1 receptor antibodies. Am J Transplant. 2013;13:2577–2589.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.